Join China Hi-Tech Fair 2024, Where Innovation Meets Global Opportunity

22.7.2024 03:30:00 EEST | Business Wire | Press release

The 26^th China Hi-Tech Fair (CHTF) is set to take place on November 14-16, 2024, at the Shenzhen World Exhibition & Convention Center. As China’s leading and most influential technology event, CHTF offers an unparalleled platform for tech companies worldwide to showcase their latest innovations, engage with industry leaders, and expand their market reach.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240721948434/en/

Embrace Innovation, Drive Growth

Over the past 25 years, CHTF has established itself as a beacon for technological advancement and international cooperation. With this year’s theme “Technology Leads Development, Industry Integrates Fusion,” the fair underscores the critical role of innovation in driving industrial integration and economic growth.

Concurrent Events

Alongside the exhibition, a lineup of over 150 concurrent events will explore groundbreaking ideas and foster collaboration. These include:

The 7th China Green Economy Summit and Chinese Cities Investment Attracting Conference
Innovative Biological Drugs and Cell Quality Progress Forum
Molecular Diagnosis and Companion Diagnosis Summit Forum
Antibody Drugs and New Drug R&D Innovation Forum
Gene Sequencing Application Development Forum
Southern University of Science and Technology Forum
International Cross-domain Cooperation and Collaborative Development of Cross-border E-commerce Forum
China Silicon Photonics Industry Forum
AI Terminal, Intelligent Positioning System New Product Launch
2024 New Quality Productivity Summit

Unparalleled Market Access and Networking Opportunities:

Unmatched Exposure: To attract over 500,000 attendees, including 150 domestic and international delegations from 105 countries and regions.
Influential Audience: To engage with more than 10,000 technological projects and 5,000 exhibitors, including 800+ listed companies and 400+ CEOs and entrepreneurs from multinational corporations.
Media Reach: To gain extensive media coverage from over 1,500 journalists representing 200 domestic and overseas media organizations, ensuring global visibility.
Industry Leaders: To network with prominent figures such as Nobel Prize winners and top industry scholars, enhancing your brand’s credibility and influence.

CHTF is where global innovation converges, serving as a gateway to China’s booming tech market. It offers invaluable insights into market trends and fosters partnerships on a global scale, making it an unmissable event for anyone involved in the technology sector.

To register as an exhibitor, please visit here.

To register as a visitor, please visit here.

For more information, please visit www.chtf.com/english/

View source version on businesswire.com: https://www.businesswire.com/news/home/20240721948434/en/

Contacts

Media Cooperation
Ms. Ocean An
ah@zhenweiexpo.com

Booth Booking
Ms. Donna Hau
hjn@zhenweiexpo.com

Visitor Enquiry
Ms. Sarah Wang
sarah@zhenweiexpo.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva26.9.2026 02:00:00 EEST | Press release

Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz™ (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric patients aged 12 years and older with fibrodysplasia ossificans progressiva (FOP). The recommended dose of Atebrioz is 100 mg administered orally, once daily. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925436454/en/ “Today marks an important milestone for people living with FOP, bringing a new treatment option to adult and pediatric patients living with this devastating disease,” said Chris Peetz, Chief Executive Officer at Mirum. “At Mirum, we are driven to serve rare disease communities where the unmet need is significant and the opportunity to make a difference is profound. The approval of Atebrioz reflects what can be achieved when industry, researchers

Digital Reef Signs Offtake Agreement with Oreasoc Agriculture to Mitigate the Environmental Footprint of Data Centre Growth Through Rainforest Protection, Appointing Xange.com as Digital MRV Partner25.9.2026 22:19:00 EEST | Press release

At Climate Week NYC, Digital Reef and Oreasoc Agriculture Inc. sign an offtake agreement connecting Digital Reef’s 3.3 GW data centre pipeline with environmental assets exceeding 30 million hectares of South American Amazon rainforest, mitigating the environmental footprint of data centre growth through rainforest protection and restoration where Oreasoc works alongside local communities to protect biodiversity, develop sustainable economies and safeguard their territories. Xange.com are appointed as digital MRV technology partner to monitor the data centres and rainforest where Digital Reef will purchase verified environmental assets generated by Oreasoc, supporting the development of low-carbon data centres mitigating their environmental footprint through the protection of high-integrity natural ecosystems across the South American Amazon, whilst advancing sustainable economic development. AI and data centre demand is driving rapid growth, with the International Energy Agency project

NetApp Announces Intent to Acquire PEAK:AIO to Advance Scalable AI Infrastructure Architecture25.9.2026 16:00:00 EEST | Press release

NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced its intent to acquire PEAK:AIO, a pioneer in next-generation metadata architecture and high-performance parallel file systems. The planned acquisition is expected to accelerate NetApp's AI infrastructure roadmap by augmenting metadata services and parallel namespace innovation designed to help AI clouds scale shared storage alongside growing GPU clusters. As AI becomes embedded in every enterprise workload, organizations are confronting a new challenge: traditional storage architectures were not designed for the unprecedented scale, concurrency, and performance requirements of AI factories, AI clouds, and next-generation data-intensive applications. NetApp is building an architecture that disaggregates metadata from data and enables metadata services to scale independently, creating a foundation for AI infrastructure capable of supporting trillions of files, exabyte-scale environments, and massively pa

MultiBank Group Secures Two Awards at Forex Expo Dubai 202625.9.2026 15:57:00 EEST | Press release

MultiBank Group, one of the world’s largest financial derivatives institutions, received two awards during its participation at Forex Expo Dubai 2026, held on 22 and 23 September at Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925539591/en/ MultiBank Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The first award recognised the strength and breadth of MultiBank Group’s global institutional offering, which brings together trading, liquidity, technology, infrastructure, execution, market access and tailored client solutions within an integrated financial ecosystem. The second award acknowledg

Croma-Pharma Introduces saypha ® volume prime Lidocaine25.9.2026 15:04:00 EEST | Press release

Croma-Pharma introduces saypha® volume prime Lidocaine, a cross-linked hyaluronic acid dermal filler that replaces saypha® volume Lidocaine within the company's saypha® portfolio. The new product offers physicians a more versatile solution with expanded indications for both midface volumization and nasolabial folds, backed by strong clinical data. 1,2 saypha® volume prime Lidocaine demonstrated non-inferiority to comparatora in a randomized, subject- and evaluator-blinded, controlled, non-inferiority multicenter, parallel group comparison study with almost 500 patients.2 In the clinical evaluation, a high patient satisfaction highlights improved midface fullness, smoothness and contour, consistent with a rheologic profile designed to provide volumization in the mobile midface.b,2 With saypha® volume prime Lidocaine, Croma-Pharma further strengthens its product range, reflecting the company's long-standing commitment to scientific excellence and continuous product innovation, and provid

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom